These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7706907

  • 1. The antiplatelet activity of ancrod on administration to rabbits.
    Chang MC, Huang TF.
    J Lab Clin Med; 1995 Apr; 125(4):508-16. PubMed ID: 7706907
    [Abstract] [Full Text] [Related]

  • 2. Platelet aggregation following defibrination with ancrod.
    Slade CL, Andes WA, Mason AD.
    Thromb Haemost; 1976 Nov 30; 36(2):424-9. PubMed ID: 1036842
    [Abstract] [Full Text] [Related]

  • 3. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
    Teng CM, Ko FN, Tsai IH, Hung ML, Huang TF.
    Thromb Haemost; 1993 Mar 01; 69(3):286-92. PubMed ID: 8470053
    [Abstract] [Full Text] [Related]

  • 4. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
    Bell WR, Shapiro SS, Martinez J, Nossel HL.
    J Lab Clin Med; 1978 Apr 01; 91(4):592-604. PubMed ID: 641385
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG, Frojmovic MM, Tang SS, White JG.
    Am J Pathol; 1984 Feb 01; 114(2):336-45. PubMed ID: 6696046
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of staphylokinase on platelet aggregation.
    Suehiro A, Oura Y, Ueda M, Kakishita E.
    Thromb Haemost; 1993 Nov 15; 70(5):834-7. PubMed ID: 7510426
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE, Argiriou S, Alesci S, Kucher K, Müller-Peltzer H, Rübsamen K, Heene DL.
    Ann N Y Acad Sci; 2001 Nov 15; 936():210-4. PubMed ID: 11460476
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C, Wallén NH, Rooney C, Fitzgerald D, Hjemdahl P.
    Thromb Haemost; 2006 Apr 15; 95(4):652-8. PubMed ID: 16601836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ.
    J Clin Invest; 1994 Jan 15; 93(1):204-11. PubMed ID: 8282789
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG, Nelson SR, Hampton KK, Casali B, Boothby M, Prentice CR.
    Blood Coagul Fibrinolysis; 1990 Oct 15; 1(4-5):385-8. PubMed ID: 2133215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.